BESCHICHTETE GEGENSTÄNDE

European patent · EP1299753 · Deleted

Register entry

Publication number
EP1299753
Application number
EP01945203
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 28, 2001
Published
Apr 9, 2003
Granted
May 12, 2004
Deleted
May 12, 2004
Reason
No effect for Switzerland and Liechtenstein
IPC classes
G02B 1/04 (2006.01)
A61L 27/34 (2006.01)
Priority
EP 00111526 30.05.2000
US 228022 P 24.08.2000
PCT application
PCT/EP2001/006082 28.05.2001
PCT publication
WO2001/092924 06.12.2001
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 15, 2004

    Change

    Published in +pat+ No 21 in 2004

  2. May 14, 2004

    Granted

    Published in +pat+ No 9 in 2004

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

CHABRECEK, Peter

CH-4125 Riehen

LOHMANN, Dieter

CH-4142 Münchenstein

LEUKEL, Jörg

D-79110 Freiburg, DE

WINTERTON, Lynn, Cook

Alpharetta, GA 30201, US

QIU, Yongxing

Duluth, GA 30097, US

LALLY, John, Martin

Lilburn, GA 30047, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.